Correlation Between Tempest Therapeutics and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Akari Therapeutics PLC, you can compare the effects of market volatilities on Tempest Therapeutics and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Akari Therapeutics.
Diversification Opportunities for Tempest Therapeutics and Akari Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Tempest and Akari is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Akari Therapeutics
Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 7.42 times more return on investment than Akari Therapeutics. However, Tempest Therapeutics is 7.42 times more volatile than Akari Therapeutics PLC. It trades about 0.03 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.03 per unit of risk. If you would invest 146.00 in Tempest Therapeutics on September 4, 2024 and sell it today you would lose (51.00) from holding Tempest Therapeutics or give up 34.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 99.8% |
| Values | Daily Returns |
Tempest Therapeutics vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Tempest Therapeutics |
| Akari Therapeutics PLC |
Tempest Therapeutics and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Akari Therapeutics
The main advantage of trading using opposite Tempest Therapeutics and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Tempest Therapeutics vs. Candel Therapeutics | Tempest Therapeutics vs. Cingulate Warrants | Tempest Therapeutics vs. Unicycive Therapeutics | Tempest Therapeutics vs. Cardio Diagnostics Holdings |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |